Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryoport (CYRX) Shares Outstanding (Weighted Average) (2016 - 2025)

Cryoport (CYRX) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $50.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 1.46% to $50.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.1 million through Dec 2025, up 1.46% year-over-year, with the annual reading at $50.1 million for FY2025, 1.46% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $50.1 million at Cryoport, roughly flat from $50.1 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $50.1 million in Q3 2025, with the low at $43.8 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $48.5 million, with a median of $49.1 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 20.69% in 2021, then fell 2.61% in 2023.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $45.9 million in 2021, then grew by 6.66% to $49.0 million in 2022, then fell by 0.51% to $48.7 million in 2023, then increased by 1.26% to $49.3 million in 2024, then rose by 1.46% to $50.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $50.1 million, $50.1 million, and $50.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.